It Takes Two (Genomes) to Cancer: Paired Viral and Host Transcriptome Analysis Provides New Insights about EBV

Sam M Mbulaiteye1, Ludmila Prokunina-Olsson2

  • 1Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.

Cancer Research
|December 4, 2019
PubMed

Insights

Epstein-Barr virus (EBV) research is advancing. A new analysis of RNA sequencing data reveals insights into EBV

Area of Science:

  • Viral oncology
  • Cancer research
  • Molecular biology

Background:

  • Epstein-Barr virus (EBV) discovery in 1964 initiated viral oncology.
  • Understanding EBV's role as a carcinogen and therapeutic target remains limited despite advances in other oncogenic viruses.
  • Significant scientific and clinical developments have occurred in research on other viruses linked to cancer risk.

Purpose of the Study:

  • To reanalyze public RNA-sequencing data to understand EBV carcinogenicity mechanisms.
  • To identify new leads for translational applications targeting EBV in cancer.
  • To investigate the interplay between the viral and host transcriptome in EBV-associated cancers.

Main Methods:

  • Massive reanalysis of public RNA-sequencing data.
  • Analysis of 291 control and 1,051 tumor samples across 15 cancer types.
  • Paired analysis of viral and host transcriptome.

Main Results:

  • The study provides a comprehensive analysis of EBV's impact on the host transcriptome.
  • New insights into the molecular mechanisms underlying EBV-driven carcinogenesis were uncovered.
  • Identification of potential therapeutic targets and biomarkers for EBV-associated cancers.

Conclusions:

  • The findings enhance our understanding of EBV carcinogenicity.
  • The study offers novel avenues for developing targeted therapies against EBV-associated malignancies.
  • This research provides a foundation for future translational applications in viral oncology.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
653
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K